Quick Answer
Neuronetics, Inc. reported Stockholders Equity of $22.38 million for the year ending 2025.
- Neuronetics, Inc. showed a decrease of -19.2% in Stockholders Equity from 2024 to 2025.
- This data is from Neuronetics, Inc.'s annual report (Form 10-K), filed with the SEC on March 17, 2026.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2018: -$197.97 million | Q2 2018: -$205.27 million | Q3 2018: $76.35 million | Q1 2019: $65.42 million | Q2 2019: $59.82 million | Q3 2019: $54.33 million | Q1 2020: $36.51 million | Q2 2020: $29.44 million | Q3 2020: $27.48 million | Q1 2021: $101.97 million | Q2 2021: $97.17 million | Q3 2021: $91.08 million | Q1 2022: $76.60 million | Q2 2022: $68.42 million | Q3 2022: $62.99 million | Q4 2022: $57.06 million | Q1 2023: $48.35 million | Q2 2023: $45.48 million | Q3 2023: $37.94 million | Q1 2024: $27.66 million | Q2 2024: $19.39 million | Q3 2024: $9.38 million | Q1 2025: $35.45 million | Q2 2025: $27.15 million | Q3 2025: $27.36 million.
- Over the full 11 years of available data (2015 to 2025), Neuronetics, Inc.'s Stockholders Equity has grown by 113.5%.
- Historical annual values: Fiscal year 2025: $22.38 million | Fiscal year 2024: $27.71 million | Fiscal year 2023: $34.19 million | Fiscal year 2022: $57.06 million | Fiscal year 2021: $85.18 million | Fiscal year 2020: $25.49 million | Fiscal year 2019: $47.85 million | Fiscal year 2018: $71.04 million | Fiscal year 2017: -$192.65 million | Fiscal year 2016: -$177.12 million | Fiscal year 2015: -$166.12 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: